- Home
- KALV vs THFF Comparison
KALV vs THFF Comparison
Compare KALV & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- THFF
- Stock Information
- Founded
- KALV N/A
- THFF 1984
- Country
- KALV United States
- THFF United States
- Employees
- KALV N/A
- THFF N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- THFF Major Banks
- Sector
- KALV Health Care
- THFF Finance
- Exchange
- KALV Nasdaq
- THFF Nasdaq
- Market Cap
- KALV 563.1M
- THFF 613.7M
- IPO Year
- KALV N/A
- THFF N/A
- Fundamental
- Price
- KALV $11.45
- THFF $49.20
- Analyst Decision
- KALV Strong Buy
- THFF Buy
- Analyst Count
- KALV 8
- THFF 2
- Target Price
- KALV $24.83
- THFF $56.50
- AVG Volume (30 Days)
- KALV 567.9K
- THFF 99.4K
- Earning Date
- KALV 03-12-2025
- THFF 04-29-2025
- Dividend Yield
- KALV N/A
- THFF 4.15%
- EPS Growth
- KALV N/A
- THFF N/A
- EPS
- KALV N/A
- THFF 4.00
- Revenue
- KALV N/A
- THFF $201,592,000.00
- Revenue This Year
- KALV N/A
- THFF $26.41
- Revenue Next Year
- KALV N/A
- THFF $2.60
- P/E Ratio
- KALV N/A
- THFF $12.27
- Revenue Growth
- KALV N/A
- THFF N/A
- 52 Week Low
- KALV $7.30
- THFF $34.58
- 52 Week High
- KALV $15.50
- THFF $53.60
- Technical
- Relative Strength Index (RSI)
- KALV 47.44
- THFF 45.02
- Support Level
- KALV $11.83
- THFF $49.69
- Resistance Level
- KALV $12.50
- THFF $50.79
- Average True Range (ATR)
- KALV 0.58
- THFF 1.22
- MACD
- KALV -0.16
- THFF -0.07
- Stochastic Oscillator
- KALV 19.46
- THFF 30.90
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.